Experimental allergic encephalomyelitis (EAE) is an autoimmune disease that can be induced in laboratory animals by immunization with the major myelin proteins, myelin basic protein (MBP) and proteolipid protein (PLP). We analyzed the role of the T cell receptor (TCR) repertoire in susceptibility to EAE induced by these two autoantigens. Autoreactive T cells induced after immunization with MBP use a limited set of TCR. In contrast, we demonstrate that T cell clones that recognize the encephalitogenic PLP epitope (PLP 139-151) use diverse TCR genes. When the TCR. repertoire is limited by introduction of a novel rearranged TCR V/~ 8.2 chain in transgenic SJL mice, EAE could be induced in the transgenic mice by immunization with the encephalitogenic epitopes of PLP, but not with the encephalitogenic epitope of MBP. Thus, skewing the TCR repertoire affects the susceptibility to EAE by immunization with MBP but not with PLP. These data demonstrate the biological consequences of the usage of a more diverse T cell repertoire in the development of an autoimmune disease. E xperimental autoimmune encephalomyelitis (EAE), an animal model of human multiple sclerosis (MS) (1), can be induced in laboratory animals by immunization with the major myelin proteins, myelin basic protein (MBP) or myelin proteolipid protein (PLP) (2, 3). The EAE that results from immunization with MBP is mediated by T cells that utilize limited sets of TCR (4-6). PLP, which constitutes the bulk of the myelin proteins in the central nervous system (CNS), is an equally important candidate antigen for MS. A panel of T cell clones specific for the encephalitogenic epitope of PLP 139-151 was recently isolated and characterized (7). Cloning and sequencing of the TCR genes reveals that diverse TCR c~/~ chains are used by these clones. We demonstrate the consequence of the diversity of TCR gene usage in response to PLP and MBP by analyzing the effect of skewing the TCR repertoire on the pathogenesis and susceptibility to EAE in SJL-TCR. V/3 8.2 transgenic mice.
Summary
Experimental allergic encephalomyelitis (EAE) is an autoimmune disease that can be induced in laboratory animals by immunization with the major myelin proteins, myelin basic protein (MBP) and proteolipid protein (PLP). We analyzed the role of the T cell receptor (TCR) repertoire in susceptibility to EAE induced by these two autoantigens. Autoreactive T cells induced after immunization with MBP use a limited set of TCR. In contrast, we demonstrate that T cell clones that recognize the encephalitogenic PLP epitope (PLP 139-151) use diverse TCR genes. When the TCR. repertoire is limited by introduction of a novel rearranged TCR V/~ 8.2 chain in transgenic SJL mice, EAE could be induced in the transgenic mice by immunization with the encephalitogenic epitopes of PLP, but not with the encephalitogenic epitope of MBP. Thus, skewing the TCR repertoire affects the susceptibility to EAE by immunization with MBP but not with PLP. These data demonstrate the biological consequences of the usage of a more diverse T cell repertoire in the development of an autoimmune disease. E xperimental autoimmune encephalomyelitis (EAE), an animal model of human multiple sclerosis (MS) (1), can be induced in laboratory animals by immunization with the major myelin proteins, myelin basic protein (MBP) or myelin proteolipid protein (PLP) (2, 3) . The EAE that results from immunization with MBP is mediated by T cells that utilize limited sets of TCR (4) (5) (6) . PLP, which constitutes the bulk of the myelin proteins in the central nervous system (CNS), is an equally important candidate antigen for MS. A panel of T cell clones specific for the encephalitogenic epitope of PLP 139-151 was recently isolated and characterized (7) . Cloning and sequencing of the TCR genes reveals that diverse TCR c~/~ chains are used by these clones. We demonstrate the consequence of the diversity of TCR gene usage in response to PLP and MBP by analyzing the effect of skewing the TCR repertoire on the pathogenesis and susceptibility to EAE in SJL-TCR. V/3 8.2 transgenic mice.
Materials and Methods
Animals. Female SJL/J mice (4-8-wk-old) were from the Jackson Laboratory (Bar Harbor, ME). Transgenic mice were produced by injecting the TcR/~ chain construct (V/~ 8.2-D/31.1-JBI.I-CB2) (8) , derived from an OVA-specific T cell hybridoma, into the product of a (C57BL/6 x SJL)F: mating. The founder animal was backcrossed twice to SJL/J mice and the offspring were H-2 typed. The H-2 s/~ homozygotes were then backcrossed an additional four times to SJL/J mice. This strain was termed SJL transgenic and was maintained by backcrosses to SJL mice. In all experiments, nontransgenic mice were littermates of transgenic mice.
Antigens. Whole mouse myelin was prepared from the brains and spinal cords by the method of Norton and Poduslo (9 T Cell Clones and Hybridomas. The five T cell clones used have been described (7) . Hybridomas were prepared (10) from each of the clones and were used to isolate some TCR genes.
Cloning and Sequendng of TCR Genes. Full-length cDNA clones for TCR~ from 5B6, 7A5, and 4E3 and for TCR3 from 7A5 and 4E3 were isolated from unamplified XZap (Stratagene, La Jolla, CA) libraries, and the DNA sequence of multiple clones were determined. The SPLI.1 TCRoe was identified using inverse PCR (11) using two Cc~ primers. The full-length cDNA clone was then isolated by using a primer specific for the predicted Vcd5 leader sequence (AAATTTGAATTCATGAAGACATCCCTTCACACT-GTA) with 3' Cc~ (AAATTTGAATTCAACTGGACCACAGCC-TCA) primers. The 2E5 TCRc~ clone was identified by PCR using a degenerate Vc~ primer (12) and a Cc~ primer and independently cloned by PCR with the above Veal5 and Cc~ primers and sequenced. The 2E5 and SPLI.1 TCR 3 chains were isolated by PCR with a V317a specific primer (ATGGGTGCAAGACTGCTCTGC-TGTGTAGCA) or V32 primer (ATGTGGCAGTTTTCCATT-CTGTGCCTCTGC), and a 3' C3 (AAATTTGAATTCTGATGT-TCTGTGTGACAGGT) primer. The 5B6 TCR3 clones were isolated by PCR using a degenerate V3 oligonucleotide (13) and the 3' C3 primer; sequence of clones from a second PCR reaction with V~6 and C3 primers confirmed that this was derived from a fulllength transcript.
In Vitro Proliferation. Mice were immunized subcutaneously with 100/zg of PLP or MBP peptides in 0.1 ml of CFA containing 200 /~g of heat killed Mycobacterium tuberculosis H37RA (Difco Laboratories, Detroit, MI). Cells from inguinal, prescapular, and paraaortic lymph nodes were dissociated and cultured at 5 x 10 s cells/well with peptide in DMEM (GIBCO BRL, Gaithersburg, MD) containing 10% FCS in 96-well plates for 72 h and then pulsed with 1 #Ci of [3H]thymidine for 16-18 h. Mean thymidine incorporation from triplicate wells was calculated. Antibodies were used as culture supernatants for blocking studies.
EAE Studies. Mice were injected subcutaneously in the flank with 2 mg of whole mouse myelin or 50 or 70 nmol of peptide and 400/~g of M. tuberculosis H37Ra (Difco) in an emulsion consisting of equal volumes of water and CFA. Each mouse was also injected intravenously on day 0 and days 2, 3, or 4 with 109 heat killed Bordetella ioertussis bacilli (Pertussis vaccine lot no 264; Massachusetts Public Health Biological Laboratories, Boston, MA) or 200 ng pertussis toxin (List Biological Laboratories, Inc., Campbell, CA). Clinical assessment was carried out daily as described (7).
Brains and spinal cords were removed and fixed in 10% phosphatebuffered formalin, and paraffin-embedded sections were stained for light microscopy. Histological disease was quantified by counting inflammatory loci in meninges and parenchyma (7) . For evaluation of TCR V/~ expression in the tissues, the brains and samples of spleen and thymus were frozen in OCT compound (Miles Laboratories, Naperville, IL) and stored at -70~ 4-6/zm-thick cryostat tissue sections were immunostained with undiluted anti-TCR V3 hybridoma culture supernatants using avidin-biotin immunohistochemical staining kits (Vector Laboratories, Inc., Burlingame, CA).
Results and Discussion
We examined TCR usage in a panel of T cell clones specific for the encephalitogenic PLP epitope 139-151 (7). These PLPspecific T cell clones use a variety of TCR Vot, Jot and V3, D3, and J3 segments (Fig. 1) . Two of the T cell clones (2E5 and SPLI.1) used the same Vot15 segment in combination with different Jot segments, thereby creating diverse junctional regions. The Jot8 segment was used by clones SPLI.1 and 5B6 in combination with different Vot segments. The V3 segments were all different, with only two of the clones using the same J3 segment. A conserved junctional motif was not observed in the CDR3 region of the TCR ot or chains. In the TCR ot chain, the threonine at position 2 within the conserved GXGT motif adjacent to the predicted CDR3 region, may be selected in that it is in four of the five sequences and is present in a minority (6/47) of germline Joe segments (14) . Thus, a wider variety of the TCR genes is used in response to this PLP epitope than in response to encephalitogenic MBP epitopes. TCR 3 chain diversity has also been observed with two other encephalitogenic PLP epitopes in SJL (15) and in (PL/J x SJL)F1 mice (Kuchroo, V. K., unpublished data).
The difference between the limited TCR diversity in response to MBP determinants and the diverse response for PLP epitopes could affect susceptibility to EAE induced by these two myelin autoantigens. One prediction would be that limitation of the TCR diversity would have a profound effect on the ability of MBP, but not PLP, to induce EAE. We examined the ability of encephalitogenic MBP and PLP epitopes to induce EAE in transgenic SJL mice containing a single rearranged TCR 3 chain transgene (8, 16) . The transgene is expressed on >95% of peripheral T cells in the transgenic mice. This transgene, which is not specific for either MBP or PLP, was chosen because the TCR V38.2 is deleted in Figure 1 . Predicted amino acid sequence of V(D)J junctions of TCR oe and 3 chains from PLP-peptide 139-151 specific T cell clones. Boxed residues correspond to predicted CDR3 regions (25) . The asterisk marks the threonine residue that may be selected in TCRot. Assignments to V, D, and J segments are based on references (14, 26, 27) . Sequence data are available from EMBL/GenBank/DDBJ under accession numbers (U07653-U07662). of inflammatory lesions (Table 1) . In contrast, immunization with the dominant encephalitogenic MBP epitope 89-101 did not result in EAE in the transgenic mice, whereas the nontransgenic control mice developed typical EAE (Table 1) . These 1662 results show that limitation of the TCR/3 chain diversity to a single/3 chain gene results in loss of susceptibility to disease induction by the dominant MBP epitope but not by either of the PLP epitopes.
The difference in susceptibility to EAE suggested that both PLP peptides elicited encephalitogenic T cell responses in the transgenic mice, but that the dominant MBP determinant did not. We examined in vitro proliferation of lymph node T cells in response to the encephalitogenic determinants of MBP and PLP. Lymph node cells from mice immunized with PLP peptide proliferated in response to the immunizing PLP peptide, but not to other control PLP or MBP peptides. However, the proliferative responses of the lymph node cells isolated from the transgenic mice were reduced by a factor of three to four compared with those from nontransgenic controls (Fig. 2, A-D) . In contrast, little or no proliferative response was detected in lymph node cells isolated from transgenic mice immunized with MBP 89-101, despite the strong proliferative response observed in lymph node cells from nontransgenic littermates (Fig. 2, E and F) . Thus, the transgenic mice appear to be unable to develop a proliferative T cell response to the dominant MBP determinant 89-101. TCR-/3 transgenic mice are unable to recognize some peptides (18) probably because of limitation in the available TCR repertoire. This may account for the lack of T cell response and the lack of disease in transgenic mice immunized with MBP 89-101.
Non-V/38 § T cells, which constitute <5% of the total T cell pool in the transgenic mice (8), could be responsible for the induction of EAE with the encephalitogenic PLP determinants. The proliferative responses of lymph node cells from transgenic and nontransgenic littermate mice immunized with PIP 139-151 were examined in the presence of anti-V/38 (KJ16) mAb. The anti-V/38 mAb blocked the PLP 139-151 specific proliferative response of lymph node cells from transgenic mice, but not the response of lymph node cells from nontransgenic mice. Antibodies to other TCR V/3 chains (V/3 4, 6, and 11) did not inhibit the proliferation of transgenic lymph node cells in response to PLP 139-151 (Fig. 2, G and  H) . By immunohistochemistry, the vast majority of the T cells in the lymphoid tissue from the transgenic mice expressed V/3 8 (~95-99%) with rare, scattered cells expressing some of the other TCR V/3 (V/34 and V/36). In contrast, lymphoid tissues from the nontransgenic littermates were totally devoid of VflS-bearing cells and expressed larger numbers of TCR V/34, V/36, and other TCR V/3s (data not shown). Immunocytochemical staining of the inflammatory lesions in the CNS of the transgenic mice demonstrated the presence of V/38 + cells and virtually no other V/3-bearing T cells (Fig. 3, B and C) . Consistent with previous results (19) , the T cells constituted ~30% of the total inflammatory cell population in the EAE lesions, which corresponded to the number of V/38 + cells detected in the EAE lesions of the transgenic mice (Fig. 3 B) . In contrast, in the nontransgenic control mice (which lack V38), accumulation of T cells expressing various TCR V/3s (V/3 2, 4, 6, 7, and 14) was seen in the infiltrates, but no TCR V/38-bearing cells were detected (data not shown).
Analyses of TCK usage by MBP-specific T cell clones in mice, rats, and humans have suggested a restricted TCK Vl3 usage (4-6, 20, 21) . Both mouse and rat MBP-specific encephalitogenic T cell clones use the same Vl3 gene segment (V138.2). The "V-region disease hypothesis" (22) proposed that TCK V138.2 in association with a specific TCK Vc~ may recognize a ligand in the CNS and induce EAE. SJL mice do not express a V138.2 gene segment (17), but introduction of a V~8.2 transgene into the SJL T cell repertoire provided us with a unique opportunity to test the role of this V gene in the induction of EAE. Overexpression of a V138.2 transgene in SJL mice did not permit an immune response to MBP 89-101 (Fig. 2 F) or development of EAE ( Table 1 ). The T cell response to MBP 89-101 is largely mediated by VB17a-and V134-bearing cells (23, 24) . Limitation of the TCK 13 chain repertoire to a single rearranged 13 chain does not permit development of an immune response to this encephalitogenic MBP epitope. In contrast, the severe limitation on TCK IS chain diversity does not prevent a T cell response to encephalitogenic PLP epitopes or the induction of EAE in a susceptible mouse strain. T cells using the novel rearranged TCK/3 chain are therefore able to recognize the encephalitogenic PLP epitopes and induce EAE. Although the autoantigen(s) involved in MS has not been identified, PLP could be involved in pathogenesis of MS. Our data would suggest that T cell responses to PLP epitopes may differ from those to MBP epitopes and that this finding should be considered in the design of TCK-based therapies for MS.
